CT-342 Prolonged Hematologic Toxicity After B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) T-Cell Treatment: From Clinical Data to Ex-Vivo Studies at a Single Center

María Luisa Palacios‐Berraquero, Nerea Berrastegui, Paula Rodríguez-Márquez, Maria Erendira Calleja Cervantes, Aintzane Zabaleta, Leire Burgos, Diego Alignani, Patxi San Martín‐Úriz, Amaia Vilas‐Zornoza, Lorea Jordana, Cristina Calviño, Ángel Martín-Mallo, Saray Rodríguez-Diaz, Susana Inogés, Ascensión López-Dı́az de Cerio, Sofía Huerga, J. Rifón, Ana Alfonso Piérola, Juan José Lasarte, Mikel Hernáez, Jesús F. San Miguel, Paula Rodríguez‐Otero, Bruno Paiva, Teresa Ezponda, Juan R. Rodríguez-Madoz, Felipe PrósperClinical 2023 · DOI

BibTeX
@inproceedings{palaciosberraquero2023ct,
  author = {María Luisa Palacios‐Berraquero and Nerea Berrastegui and Paula Rodríguez-Márquez and Maria Erendira Calleja Cervantes and Aintzane Zabaleta and Leire Burgos and Diego Alignani and Patxi San Martín‐Úriz and Amaia Vilas‐Zornoza and Lorea Jordana and Cristina Calviño and Ángel Martín-Mallo and Saray Rodríguez-Diaz and Susana Inogés and Ascensión López-Dı́az de Cerio and Sofía Huerga and J. Rifón and Ana Alfonso Piérola and Juan José Lasarte and Mikel Hernáez and Jesús F. San Miguel and Paula Rodríguez‐Otero and Bruno Paiva and Teresa Ezponda and Juan R. Rodríguez-Madoz and Felipe Prósper},
  title = {{CT-342 Prolonged Hematologic Toxicity After B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) T-Cell Treatment: From Clinical Data to Ex-Vivo Studies at a Single Center}},
  booktitle = {Clinical},
  year = {2023},
  doi = {10.1016/s2152-2650(23)01508-2},
}

Loading related content...

Figure